Back to search

Biopharma Laboratories (Uk) Limited

06380604

active
Private Limited Company
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)

Details

BELFRY HOUSE, HERTFORD, SG14 1BP
Incorporated 25/09/2007

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Mr Matthew Douglas Chambers

director · Since 24/04/2009

DIRECTOR

BRITISH · ENGLAND · Age 50

Also on 5 other boards

Persons with Significant Control

Mr Matthew Douglas Chambers

75–100% shares
75–100% votes

British · England · Age 50

Unit 8 The Io Centre, Arlington Business Park, Stevenage, SG1 2BD

Notified 31/01/2019

Former PSCs

Mr Michael Chambers

Ceased 31/01/2019

CompanyRankvs 323+ SIC 21100 peers
57

Financial strength3th percentile among SIC peers · 1/25
Employees68th percentile among SIC peers · 10/15
LiquidityCurrent ratio 1.86× · 16/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

-£334k

Balance sheet strength

Cash

£267

Cash in the bank

Net Current Assets

£128k

Working capital

Current Assets

£277k

Current Liabilities

£149k

Fixed Assets

£2k

Debtors

£180k

2avg. employees

Balance Sheet

Bank loans & overdrafts£23k
Assets less current liabilities£130k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20241.86-£41k
20232.24-£52k
20222.82-£16k
20213.32+£66k
20201.90-£13k
20192.88-£23k
20183.37

Derived from filed accounts. Not audited figures.